Results 1 to 10 of about 153,261 (262)
Phosphodiesterases and cAMP Pathway in Pituitary Diseases [PDF]
Frontiers in Endocrinology, 2019 Human phosphodiesterases (PDEs) comprise a complex superfamily of enzymes derived from 24 genes separated into 11 PDE gene families (PDEs 1–11), expressed in different tissues and cells, including heart and brain.
Mariana Ferreira Bizzi +4 more
doaj +2 more sources
罕见病研究, 2023 Cushing′s syndrome(CS)is a clinical syndrome caused by a variety of causes, with main manifestations exhibited by central obesity, purple skin striae, hypertension, and diabetes. In patients with adrenocorticotropic hormone(ACTH)-dependent CS, the result
Chinese Medical Association Rare Diseases Branch, Hypothalamic and Pituitary Disease Group of China Alliance of Rare Diseases (CARD) +1 more
doaj +1 more source
Hyponatremia and Oxidative Stress
Antioxidants, 2021 Hyponatremia, i.e., the presence of a serum sodium concentration ([Na+]) < 136 mEq/L, is the most frequent electrolyte imbalance in the elderly and in hospitalized patients. Symptoms of acute hyponatremia, whose main target is the central nervous system,
Benedetta Fibbi +4 more
doaj +1 more source
Endoscopy in pituitary diseases
Chinese Journal of Contemporary Neurology and Neurosurgery, 2021 The etiology pattern of pituitary diseases is diverse and complex, including pituitary adenoma, Rathke cleft cyst (RCC), pituitary apoplexy, craniopharyngioma, etc.
ZHU Jian⁃yu +2 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectiveExcessive growth hormone and insulin-like growth factor 1 contribute to cutaneous changes in acromegaly. We investigated the sub-macroscopic skin manifestation of acromegaly patients and explored its reversibility upon hormone reduction after ...
Xiaopeng Guo +7 more
doaj +1 more source
Best Achievements in Pituitary and Adrenal Diseases in 2020 [PDF]
Endocrinology and Metabolism, 2021 Significant progress in pituitary and adrenal diseases was made in 2020. This review presents major translational and clinical advances in research on pituitary and adrenal diseases, encompassing their epidemiology, pathogenesis, diagnosis, and clinical ...
Chang Ho Ahn, Jung Hee Kim
doaj +1 more source
Australian Journal of General Practice, 2021 Pituitary lesions are present in >10% of the population. Approximately one in 1000 people has a symptomatic pituitary tumour, which may cause clinical problems from mass effect, hormonal hypersecretion and impairment of normal pituitary function.The aim of this article is to outline the potential causes of a sellar and parasellar mass, with an emphasis
Inder, Warrick J., Jang, Christina
openaire +5 more sources
Brain and Spine, 2022 BackgroundSurgical and clinical management of craniopharyngiomas is associated with high long-term morbidity especially in the case of hypothalamic involvement. Improvements in knowledge of craniopharyngioma molecular biology may offer the possibility of
F. Calvanese +7 more
doaj +3 more sources
Interpretation of Consensus on Diagnosis and Management of Cushing's Disease: a Guideline Update of the International Pituitary Society——Diagnosis [PDF]
Zhongguo quanke yixue, 2022 Cushing disease, the most common cause of endogenous Cushing's syndrome characterized by hypercortisolemia, is a clinical syndrome caused by adrenocorticotropic hormone (ACTH) ——secreting pituitary adenomas.
Huiwen TAN, Yu TANG, Yerong YU, Jianwei LI, Jiaqi LI, Zhenmei AN, Chun WANG, Yi WEI
doaj +1 more source
Interpretation of Consensus on Diagnosis and Management of Cushing's Disease: a Guideline Update from the Pituitary Society——Medical Therapies [PDF]
Zhongguo quanke yixue, 2022 Cushing's disease, the most common cause of endogenous Cushing's syndrome, is hypercortisolemia caused by adrenocorticotropic hormone-secreting pituitary adenoma.
TANG Yu, TAN Huiwen, LI Jianwei, YU Yerong
doaj +1 more source